B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
about
Immunopathogenesis of granulomas in chronic autoinflammatory diseases.miR-155 Regulates IL-10-Producing CD24hiCD27+ B Cells and Impairs Their Function in Patients with Crohn's DiseaseB-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.Human IgG2- and IgG4-expressing memory B cells display enhanced molecular and phenotypic signs of maturity and accumulate with age.
P2860
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
@ast
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
@en
type
label
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
@ast
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
@en
prefLabel
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
@ast
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
@en
P2093
P2860
P1433
P1476
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
@en
P2093
Jan A M van Laar
King H Lam
Lieke S J Kamphuis
Miles P Sparrow
P Martin van Hagen
Peter R Gibson
Rob J Ouwendijk
Sophinus J W Bartol
Tim B van der Houwen
Wilhelmina M C Timmermans
P2860
P304
P356
10.1371/JOURNAL.PONE.0160103
P407
P577
2016-07-28T00:00:00Z